[Lymphocyte subpopulations in carriers of antibodies to the human immunodeficiency virus]. 1988

G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ

Changes in subpopulations of OKT 3, OKT 4, OKT 8, HNK-I, B-IgM, and B-IgG-producing lymphocytes in carriers of HIV antibodies were studied. A decrease in OKT 4 helpers/inducers, an increase in OKT 8-suppressors of cytotoxic cells, HNK-I, Ia-positive and B-IgM-producing lymphocytes was demonstrated. The ratio of OKT 4/OKT 8 lymphocytes was below 1.0 in most of the subjects examined. Most marked changes in lymphocyte subpopulations were observed in anti-HIV carriers with lymphadenopathy.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000349 Africa The continent south of EUROPE, east of the ATLANTIC OCEAN and west of the INDIAN OCEAN.
D000386 AIDS-Related Complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS. ARC,Lymphadenopathy Syndrome,AIDS Related Complex,Complex, AIDS-Related,Lymphadenopathy Syndromes,Syndrome, Lymphadenopathy,Syndromes, Lymphadenopathy
D014586 USSR A country located from the Baltic and Black seas to the Pacific Ocean and, for a time including 15 Soviet Socialist Republics. The capital was Moscow. Soviet Union,Union of Soviet Socialist Republics
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
February 1991, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
December 1992, American journal of obstetrics and gynecology,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
January 1982, Indian journal of pediatrics,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
May 1983, Archives of disease in childhood,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
March 1988, Annales medico-psychologiques,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
February 1983, British journal of haematology,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
January 1980, Seminars in hematology,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
September 1984, Transplantation,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
March 1989, Proceedings of the National Academy of Sciences of the United States of America,
G I Savitskiĭ, and N N Zhilina, and I L Alekseeva, and K V Morgunov, and E P Shumaĭ
September 1979, Thymus,
Copied contents to your clipboard!